Surrozen Inc (SRZN)
10.09
-0.06
(-0.62%)
USD |
NASDAQ |
May 16, 16:00
10.09
0.00 (0.00%)
After-Hours: 20:00
Surrozen Shareholders Equity (Quarterly): 30.14M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 30.14M |
| December 31, 2023 | 37.94M |
| September 30, 2023 | 45.53M |
| June 30, 2023 | 55.06M |
| March 31, 2023 | 63.04M |
| December 31, 2022 | 76.00M |
| Date | Value |
|---|---|
| September 30, 2022 | 77.49M |
| June 30, 2022 | 89.70M |
| March 31, 2022 | 102.66M |
| December 31, 2021 | 109.70M |
| September 30, 2021 | 123.73M |
| December 31, 2020 | 47.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
30.14M
Minimum
Mar 2024
123.73M
Maximum
Sep 2021
71.52M
Average
69.52M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 12.65M |
| AIM ImmunoTech Inc | 10.23M |
| IGC Pharma Inc | 9.053M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.72M |
| Total Liabilities (Quarterly) | 6.58M |